All Comments by

  1. David Teplow on Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
  2. Patricia C. Heyn on Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.
  3. Mark Cookson on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
  4. Paul Coleman on Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.
  5. Paul Coleman on Widespread changes in dendritic spines in a model of Alzheimer's disease.
  6. Paul Coleman on Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
  7. Terrence Town on AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
  8. Elena Galea on Research Brief—Flurizan Fails Final Hurdle, Company Discontinues Drug
  9. Avi Friedlich on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
  10. Julie Andersen on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
  11. Stuart Kim on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
  12. Volkmar Lessmann on Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons.
  13. Leonidas Stefanis on Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease.
  14. Todd E. Golde on AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
  15. George Martin on Age-specific epigenetic drift in late-onset Alzheimer's disease.